R. Michael Carruthers is CFO at Edgewise Therapeutics, Inc. (EWTX). They have made 6 open-market trades across 2 companies since 2016, most recently 2025-08-12.
CIK 0001644467
1 open-market purchase totalling $50K since 2016, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EWTX | SELL | 2025-08-12 | 2025-08-14 | $13.39 | $19K | +4.4% | -2.0% | +51.4% |
| EWTX | SELL | 2025-05-02 | 2025-05-07 | $16.45 | $22K | +1.9% | +5.0% | -5.3% |
| EWTX | SELL | 2024-09-20 | 2024-09-24 | $28.58 | $5.7M | +12.6% | +37.2% | +18.8% |
| EWTX | SELL | 2024-05-02 | 2024-05-03 | $18.91 | $41K | -8.4% | -9.8% | -13.2% |
| EWTX | SELL · 10b5-1 | 2024-01-23 | 2024-01-25 | $15.78 | $1.4M | +22.6% | +6.4% | +0.6% |
| EWTX | SELL | 2023-05-02 | 2023-05-03 | $8.90 | $12K | -2.1% | +5.3% | -23.5% |
| NVLS | BUY | 2016-12-02 | 2016-12-05 | $2.09 | $50K | -3.7% | +11.1% | +22.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.